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Background: Rapid activation of innate immune defences upon microbial infection depends on the evolutionary
conserved NF-κB dependent signals which deregulation is frequently associated with chronic inflammation and
oncogenesis. These signals are tightly regulated by the linkage of different kinds of ubiquitin moieties on proteins
that modify either their activity or their stability. To investigate how ubiquitin specific proteases (USPs) orchestrate
immune signal regulation, we created and screened a focused RNA interference library on Drosophila NF-κB-like
pathways Toll and Imd in cultured S2 cells, and further analysed the function of selected genes in vivo.
Results: We report here that USP2 and USP34/Puf, in addition to the previously described USP36/Scny, prevent
inappropriate activation of Imd-dependent immune signal in unchallenged conditions. Moreover, USP34 is also
necessary to prevent constitutive activation of the Toll pathway. However, while USP2 also prevents excessive
Imd-dependent signalling in vivo, USP34 shows differential requirement depending on NF-κB target genes, in
response to fly infection by either Gram-positive or Gram-negative bacteria. We further show that USP2 prevents
the constitutive activation of signalling by promoting Imd proteasomal degradation. Indeed, the homeostasis of the
Imd scaffolding molecule is tightly regulated by the linkage of lysine 48-linked ubiquitin chains (K48) acting as a tag
for its proteasomal degradation. This process is necessary to prevent constitutive activation of Imd pathway in vivo
and is inhibited in response to infection. The control of Imd homeostasis by USP2 is associated with the hydrolysis
of Imd linked K48-ubiquitin chains and the synergistic binding of USP2 and Imd to the proteasome, as evidenced
by both mass-spectrometry analysis of USP2 partners and by co-immunoprecipitation experiments.
Conclusion: Our work identified one known (USP36) and two new (USP2, USP34) ubiquitin specific proteases
regulating Imd or Toll dependent immune signalling in Drosophila. It further highlights the ubiquitin dependent
control of Imd homeostasis and shows a new activity for USP2 at the proteasome allowing for Imd degradation.
This study provides original information for the better understanding of the strong implication of USP2 in
pathological processes in humans, including cancerogenesis.
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Inflammation is a major player of our innate immune
defences which is induced within minutes following
infection by microorganisms. Its activation mainly de-
pends on intracellular signals inducing the secretion of
pro-inflammatory cytokines and anti-microbial mole-
cules. This high reactivity implies mechanisms pre-
venting inappropriate activation of pro-inflammatory
immune signals that can otherwise favours cancer pro-
gression or induce tissue damages such as those occur-
ring in auto-immune diseases. We used Drosophila
flies model system for the identification of new en-
zymes of the ubiquitin specific protease family regulat-
ing evolutionary conserved immune signals in both
Drosophila and Humans. These enzymes specifically
control the stability or the activated status of target
proteins by hydrolysing a small peptide, called ubiquitin,
which is linked as a monomer or polymers on protein.
Moreover, they constitute promising and yet poorly ex-
plored targets for the finding of drugs useable as thera-
peutic molecules. We found a set of three ubiquitin specific
proteases regulating immune signals in response to infec-
tions, among which USP2 controls the homeostasis of an
essential signalling component -named Imd- by promoting
its degradation at the proteasome. Beyond the immune re-
sponse, this work highlights how a specific enzyme, USP2,
may regulate its targets in physio-pathological processes for
a better understanding of its pathogenic activity in cancers
and inflammation.
Background
Conjugation of ubiquitin monomers or polymers to
proteins is a key mechanism for controlling their activ-
ity or stability [1]. Lysine (Lys) residues of proteins can
be modified by a single ubiquitin monomer or by poly-
mers of ubiquitin (polyubiquitin) each linked through
Lys 48 (K48) or through Lys63 (K63) of the ubiquitin
molecule, or by other kinds of polymers. Whereas
K48-linked polyubiquitin (UbK48) mainly triggers deg-
radation of proteins by the proteasome, monoubiquiti-
nation, K63-linked polyubiquitin (UbK63) and other
polyubiquitin chains regulate the activity, the conform-
ation or the subcellular localisation of proteins [2,3].
Mammalian genomes contain about one hundred ubi-
quitin proteases – the enzymes that remove ubiquitin
moieties from proteins- that are divided in five sub-
families, among which the Ubiquitin Specific Proteases
(USPs) subfamily represents the major class in both
human and Drosophila [4-7]. The NF-κB dependent signal-
ling pathways, that are central to pro-inflammatory and im-
mune signalling, are tightly regulated by the ubiquitination
of several of their protein components including RIP1,
interacting with the tumour necrosis factor receptor 1
(TNF-R1), and downstream protein kinase complexes[5,8]. A growing number of ubiquitin proteases have
been found to mediate transient inhibition of NF-κB- path-
ways frequently sharing a same target which raises the
question of their specificity and functional interrelation-
ships [5].
In Drosophila, two conserved NF-κB-like signalling
pathways, Toll and Imd, contribute to innate immunity
by promoting the expression of antimicrobial peptide
(AMP) encoding genes -mainly in fat body cells- in re-
sponse to infections [9]. The Toll receptor is activated
by binding of the processed cytokine Spätzle (Spz),
whose cleavage depends on upstream extracellular pro-
teolytic cascades initiated by circulating peptidoglycan
recognition proteins (PGRPs) following the recognition
of various pathogens associated patterns, such as the
Lys-type peptidoglycans from Gram-positive bacteria
[10,11]. Activated Toll associates with adaptor proteins
dMyd88 and Tube, ultimately resulting in the activation
of the NF-κB like factors, Dif and/or Dorsal (DL), which
activate the transcription of a set of AMP encoding
genes including Drosomycin (Drs), immune induced
molecule 1 (IM1) and Attacin (AttA) [10,12-14]. The
Imd pathway is induced by the direct binding of diami-
nopimelic acids containing bacterial peptidoglycan frag-
ments to the transmembrane receptor PGRP-LC/Ird7
and results in the activation of another set of AMPs en-
coding genes, including Diptericin (Dpt), Defensine (Def )
and Attacin A (AttA) [12]. PGRP-LC associates with the
cytoplasmic scaffolding protein Imd [15] which mediates
the activation of Tak1 and Kenny (Key), the Drosophila
IKKγ homolog, resulting in the phosphorylation of the
NF-κB like factor Relish (Rel) [16].
We have previously demonstrated that Imd is ubiquiti-
nated by UbK63 and that the ubiquitin specific protease
USP36/Scny negatively regulates signal transduction by
hydrolysing UbK63 from Imd [17]. Complex regulation
of immune signals by ubiquitin-dependent mechanisms
prompted us to identify other ubiquitin specific prote-
ases (USPs) acting in Imd and Toll dependent immune
signalling. To this end, we have designed and screened
an RNAi library targeting the Drosophila USPs in S2
cells. We report here the identification of three regula-
tors of the Imd pathway: the already described USP36
and two new USPs, USP2 and USP34/Puf (Puffyeye
[18]), and of one regulator of the Toll pathway: USP34.
We demonstrate that USP2 and USP34 are required to
prevent constitutive activation of immune signalling
in vivo. However, while USP2 is also required to prevent
excessive activation of the Imd pathway in infected flies,
USP34 displays differential requirement depending on the
antimicrobial peptide gene analysed: silencing Usp34 en-
hanced the activation of AttA, Drs and IM1. In the oppos-
ite, USP34 is required for full activation of the two specific
Imd-dependent genes Dpt and Def in response to
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plex requirement of USP34 in these two pathways.
Focusing on USP2 biochemical function, we show that
USP2 binds to Imd and promotes the cleavage of
UbK48 chains from the protein in both cultured cells
and flies. Surprisingly, USP2 also targets Imd for degrad-
ation, a function which, from our proteomic analysis of
USP2 partners and subsequent co-immunoprecipitation
experiments, likely occurs at the level of the proteasome.
Interestingly, UbK48 chains linkage on Imd, acting as a tag
for its proteasomal degradation, is fully prevented in re-
sponse to infection therefore ensuring the required protein
stabilisation for signal transduction. Thus, Imd homeostasis
is tightly regulated by ubiquitination and USP2 controls
Imd pathway activation by regulating the steady-state level
of the Imd protein.
Results
Three USPs regulate the Imd pathway in S2 cells
We created a double strand RNA interference (dsRNA)
library targeting USPs encoded in the Drosophila gen-
ome (Additional file 1: Table S1) (see also [7,19]). This
library was screened in Drosophila S2 cells on PGRP-
LC-dependent activation of Imd pathway mediated by
adding heat-killed Escherichia coli (E. coli) in the culture
medium. Activation of the pathway was monitored by
using an Attacin-luciferase (AttA-luc) reporter gene
and the signal was normalised to that from a control
Actin-luciferase (Act-luc) reporter gene [20]. Silencing
Usp2, Usp34 and Usp36 genes resulted in over-activation of
the Imd dependent AttA promoter whereas silencing the
other Usp genes had no significant effect (Figure 1A).
Constitutive activation of the AttA promoter was also de-
tected when the same three Usp genes were silenced in the
absence of heat-killed E. coli (Figure 1B). Monitoring Usp2,
Usp34 and Usp36 transcripts in RNAi-treated cells showed
effective gene silencing (Additional file 2: Figure S1).
Activation of the Imd pathway in Usp2, Usp34 and Usp36
silenced cells was strictly dependent on the NF-κB like
protein Rel since co-silencing Rel with each of these three
genes fully prevented activation of the AttA promoter
(Figure 1C). Co-silencing Imd with either Usp2 or Usp34
strongly decreased the induction observed in only Usp2- or
Usp34-silenced cells indicating a crucial contribution of
Imd (Figure 1C). Finally, as expected from our previous
findings demonstrating that USP36 directly targets Imd
[17], we observed no induction of AttA when Imd and
Usp36 were co-silenced in S2 cells (Figure 1C). This screen
thus defines USP2, USP34 and USP36 as inhibitors of the
Imd pathway in S2 cells.
USP34 inhibits the Toll pathway in S2 cells
To identify ubiquitin proteases regulating the Toll path-
way, we activated this pathway by expressing Spz -theligand of Toll- in S2 cells. Expression of a Drs-luc
reporter construct was monitored and normalized to
that of an Act-luc construct [21]. A preliminary assay
indicated that the NF-κB factors Dorsal (Dl) and Rel, but
not Dif, were required for the Toll-mediated activation
of the Drs promoter in S2 cells (Additional file 2: Figure S2)
as also described in a previous study [22]. Silencing
upstream components of the pathway, dMyd88 or Spz,
prevented the activation of the Drs promoter as expected
(Additional file 2: Figure S2). By contrast, silencing up-
stream components of the Imd pathway, PGRP-LC, Imd,
Tab2 and Key, did not affect expression from the Drs pro-
moter induced by Spz, indicating that Rel is the sole Imd
pathway component contributing to Toll activation in S2
cells (Additional file 2: Figure S2). Screening the RNAi li-
brary in Spz-expressing cells revealed that Usp34 silencing
resulted in a significant enhancement of Drs promoter
activity when compared to control cells (Figure 1D). Simi-
larly, Usp34 was the only gene whose silencing induced
the Drs promoter in cells not expressing Spz (Figure 1E).
This activation was strictly dependent on downstream
NF-κB factors (Rel and Dl) and on the adaptor protein
dMyd88 (Figure 1F). We therefore identified USP34 as a
new inhibitor of the Toll pathway both in stimulated and
un-stimulated cells.
Overexpressing USP2 or USP34 suppresses fly immunity
in vivo
The USP36 negative function on flies resistance to infec-
tion and antimicrobial peptide expression has been pre-
viously described [17]. To assess the function of USP2
and USP34 on immune signalling in vivo, we created a
UAS-Usp2 transgenic strain and used a P[UAS] insertion
located upstream of the Usp34 transcription unit,
P[EPgy2]ash2EY03971 (hereafter referred to as UAS-Usp34),
in order to overexpress each corresponding genes under
the control of the GAL4 transcription factor [23]. Over-
expression of these two genes was induced in adults
through the heat-shock HspGal4 driver line and was
verified by quantitative Real Time PCR at 3, 6, 9 and
12 hours post-heat shock (Additional file 2: Figure S3).
A strong diminution of Dpt expression was observed in
E. coli infected flies overexpressing USP34 and to a
lesser but significant extent, in flies overexpressing USP2
(Figure 2A). Inhibition of AMP gene expression was
associated with increased fly sensitivity to the Gram-
negative pathogen Enterobacter cloacae (Figure 2B) and
Klebsellia pneumonia (not shown). Similarly as observed
for Dpt, overexpressing USP34 significantly reduced Drs
expression at 12 and 24 hours after infection with the
non-pathogenic Gram-positive bacteriaMicrococcus luteus
(Figure 2C). This phenotype was associated with increased
fly sensitivity to the Gram-positive pathogen Enterococcus
faecalis (Figure 2D). Therefore, when overexpressed in vivo,
Figure 1 Screening USPs regulating Imd and Toll pathways. Drosophila S2 cells were co-transfected with the indicated dsRNAs, pAct-luc
normaliser and either the pAttA-luc (A-C) or the pDrs-luc (D-F) reporter gene. A,C: The Imd pathway was activated by adding heat-killed E. coli.
D,F: The Toll pathway is stimulated by co-transfecting cells with pAc-Spz. B,E: Cells are not stimulated (ie, neither by E. coli (B) not by pAc-Spz
(E)) in order to look after constitutive deregulation of the pathway. A,D,C,F. NI: not induced control. A-F. Histograms represent the % of induction
compared to double strand gfp treated control cells. One out of three independent experiments is shown. Error bars indicate standard deviation
of technical triplicates. Significant differences (Student-t-test) p < 0.05 (*), p < 0.02 (**).
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immune response to bacterial infections.
USP2 and USP34 prevent constitutive immune signalling
in vivo but differentially control antimicrobial peptide
genes expression following bacterial infection
To investigate further the functions of USP2 and USP34
in vivo, we created transgenic fly lines expressing inverted
repeats (IR) of Usp2 (Usp2-IR #5M hereafter designed as
Usp2-IR) or Usp34 (Usp34-IR #1M hereafter designed as
Usp34-IR) inducing efficient gene silencing in the living
flies (Additional file 2: Figure S4A,B). Specific silencing of
either Usp2 or Usp34 in the adult fat body was then
achieved by using the driver line c564 [24] and resulted in a
significant constitutive activation of Dpt and AttA in the
absence of immune challenge (Figure 3A). We obtainedsimilar results with other transgenes carrying different
silencing sequences designed to silence the same two
genes from the VDRC collection [25] (Additional file 2:
Figure S4A-D). In addition, a significant three-fold ac-
tivation of two Toll-pathway target genes Drs and IM1
was also observed in Usp34-silenced flies (Figure 3A).
Silencing Imd strongly reduced the constitutive activa-
tion of Imd-dependent target genes AttA and Dpt in-
duced by silencing either Usp2 or Usp34 indicating
that Imd contribute to the observed up-regulation of
these antimicrobial genes (Figure 3B). Moreover, en-
hanced activation of Dpt and AttA expression was ob-
served in Usp2-silenced flies three hours after a septic
injury with E. coli and this activation was fully pre-
vented in Imd-silenced flies (Figure 3C). Enhanced
activation of Dpt and AttA in Usp2-silenced flies was
Figure 2 Overexpressing USP2 or USP34 suppresses fly immunity in vivo. A-D. Flies were heat shocked 12 hours before infection. A.
Quantitative analysis of Dpt mRNAs levels by RT-qPCR at 3, 6, 9 and 12 hours post infection with E. coli. B. Forty heat-shocked flies of 5 days old
were infected with E. cloacae and their survival kinetics was followed over 24 hours. The mutant key is used as a Gram-negative bacteria sensitive
control (non-heat shocked flies). C. Quantitative analysis of Drs mRNAs by RT-qPCR at 12 and 24 hours post infection with M. luteus. D. Forty flies
of 5 days old were infected with E. faecalis 6 hours following heat shock treatment and their survival kinetics was followed over 48 hours. The
mutant w1118;Dif,Key is used as a Gram-positive bacteria sensitive control (non-heat shocked flies). A,C: Results are expressed as the fold induction
level compared to the level of Dpt (A) or Drs (C) mRNAs in non-infected flies. Error bars indicate standard deviation between technical replicates.
One representative experiment out of three is shown. Significant difference: p < 0.05 (*), p < 0.002 (**) or p < 0.0001 (***) compared to HspGal4/+
control flies (Student’s-t-test). B,D: Results are expressed as % of surviving flies. One representative experiment out of three is shown. Significant
difference: p < 0.002 (**) or p < 0.0001 (***) compared to HspGal4/+control flies (Log-rank (Mantel-Cox) test). A-D. Flies’ genotypes are: w1118;
HspGal4/+ (HspGal4/+), w1118;HspGal4/+; P{EPgy2}ash2EY03971/+ (Hsp > Usp34), w1118;HspGal4/+;UAS-Usp2/+ (Hsp > Usp2), w1118;key1 (key) and
w1118; Dif1, key1(Dif,key).
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hours following infection (Additional file 2: Figure
S5A).
In contrast, antimicrobial peptide gene induction upon
bacterial infection was differentially modified in Usp34-
silenced flies. Indeed, in flies infected by E. coli, the
induction of AttA was enhanced in Usp34 silenced flies
compared to control flies (Figure 3D, Additional file 2:
Figure S5C). However, the induction of Dpt expression
was significantly compromised in Usp34-silenced flies,
resulting in a 30 to 50% reduction of Dpt induction from
3 to 9 hours following infection by E. coli (Figure 3D,
Additional file 2: Figure S5C). The expression of Defen-
sin C (Def ) an additional Imd-dependent antimicrobial
peptide encoding gene, was also significantly deregulated
in both Usp34-silenced non-infected flies and at 3 hourspost-infection (Additional file 2: Figure S5B,C) but then,
it was strongly compromised from 6 to 9 hours follow-
ing E. coli infection (Additional file 2: Figure S5C).
Finally, when the Toll pathway was specifically activated
by infecting flies with M. luteus, all three target genes
analyzed, AttA, Drs and IM1 were significantly enhanced
in Usp34 silenced flies compared to control flies at
3 hours following the infection, while at 24 hours infec-
tion, up-regulation was significant only in the cases of
AttA and IM1 (Figure 3E).
These data suggest that in non-infected flies, both
USP2 and USP34 are required in fat body cells to inhibit
immune signals. However, in infected flies, USP2 is
acting as a negative regulator but USP34 is differentially
required for either the activation or the inhibition of
antimicrobial peptide genes.
Figure 3 USP2 and USP34 regulate immune signalling in vivo. Quantitative analysis of Dpt, AttA, Drs and IM1 mRNAs by RT-qPCR. A. Histograms
present the fold activation of the indicated gene mRNA in Usp2 (c564 > Usp2-IR) or Usp34 (c564 > Usp34-IR) silenced flies compared to control flies
(c564Gal4/+) raised in similar conditions. B. Dpt and AttA induction in double silenced flies (c564 > Usp2-IR, Imd-IR or c564 > Usp34-IR, Imd-IR) expressed
as a % of activity of Usp-only silenced flies (c564 > Usp2-IR or c564 > Usp34-IR, respectively). C,D. Activation of Dpt and AttA in Usp2- (C) or
Usp34 (D) -silenced flies, in combination or not with an Imd-silencing transgene-, at 3 hours post E. coli infection, expressed as a % of activity
compared to infected control flies (c564/+). E. Activation of AttA, Drs and IM1 in Usp34-silenced flies at 3 and 24 hours post M. luteus infection
expressed as a % of activity compared to infected control flies (c564/+) (100% is the maximal activation observed in control flies at 3 hours post infection
for AttA, and IM1 and at 24 hours post-infection for Drs). A-E. One representative experiment out of three is shown. Error bars indicate standard deviation
between technical triplicates. Significant differences (t-test), p < 0.05 (*), p < 0.02 (**), p < 0.001 (***).
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response to E. coli or M. luteus infections revealed no
major change in Usp2 or Usp34 gene expression (below
1,6 fold change) (Additional file 2: Figure S6). This sug-
gests that the activity or stability of these two proteases
in response to infection is mainly regulated at the pro-
tein level.USP2 interacts with Imd and promotes cleavage of
Imd-linked UbK48
We decided to focus on the function of USP2 in the Imd
pathway. So, we transfected USP2-Myc and Imd-V5 tagged
expressing constructs in S2 cells to assess whether the cor-
responding proteins interact with each other (Figure 4A).
Indeed, we observed co-immunoprecipitation of the two
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protein complex (Figure 4B). Imd is a scaffolding protein
containing a death domain located in the C-terminus part
of the protein while its N-terminus part is required for its
interaction with PGRP-LC [15,26]. Using V5 tagged Imd
truncated constructs (Figure 4A), we showed that USP2
preferentially interacts with the PGRP-LC-interacting Imd-
N-ter part in S2 cells (Figure 4B). GST pull-down assays
using GST-tagged full-length and truncated forms of Imd
expressed as recombinant proteins in bacteria confirmed
this preferential interaction (Additional file 2: Figure S7).
The catalytic domain of USP2 - containing the critical
cysteine residue required for ubiquitin chain hydrolysis
at position 540- is located in the C-terminal part of the
enzyme [27] (Figure 4A). By using GST pull-down assays
with GST-tagged full length or truncated forms of USP2
(USP2-N-ter [AA:1–531] and USP2-C-ter [AA:475–
856]), we finally showed that USP2 preferentially inter-
acts with Imd through its non-catalytic N-ter domain
(Figure 4C).
We then expressed the USP2 -C-ter catalytic domain
(USP2CD) in bacteria expressing a fusion protein of ubi-
quitin with β-galactosidase (Ub-β-gal), a substrate for
deubiquitination. We observed a clear cleavage of thisFigure 4 USP2 interacts with Imd. A. Representation of the constructs us
USP2, V5: V5 tag, Myc: Myc tag. Numbers in brackets indicate amino-acid p
constructs encoding USP2-Myc and either Imd-V5, or Imd-N-ter-V5 or Imd-C
either anti-V5 or anti-Myc antibodies and analysed by western blot (WB) w
transfected with the expression construct encoding Imd-V5 and lysed after
assays using GST fusion proteins with either the USP2-N-ter [1–531] or the
with Coomassie to visualize GST-fusion proteins in the input (bottom part).
indicated USP2CD*) catalytic domain of USP2 were coexpressed with Ub-β
cleavage was analysed by western blotting with anti-βgal antibodies.substrate indicating that Drosophila USP2 is an active
deubiquitinating enzyme (Figure 4D). Mutation of the
conserved Cys540 to Ser (C540S) resulted in no hydroly-
sis of the Ub-β-gal fusion protein (Figure 4D, USP2CD*).
To test the ability of USP2 to deubiquitinate Imd, we
co-expressed full-length USP2 with Imd in S2 cells.
Whereas the level of UbK63-Imd was not modified by
the presence of wild type or catalytically inactive full
length USP2, the amount of UbK48-Imd was reduced in
cells overexpressing USP2 but not in cells expressing its
catalytically inactive form in both untreated or MG132
treated cells (Figure 5A). This suggests that USP2 specific-
ally hydrolyses Imd-linked UbK48. Consistent with this
hypothesis, UbK48-Imd accumulated in Usp2-silenced cells
both in MG132 treated or untreated cells (Figure 5B).
To characterize the activity of USP2 on Imd-linked
ubiquitin chains in vivo, we immunoprecipitated the en-
dogenous Imd protein from flies extracts. Silencing Usp2
resulted in the accumulation of UbK48-Imd (Figure 5C).
On the opposite, expressing USP2, but not the catalytic
mutant, resulted in a strong diminution of immunoprecipi-
tated UbK48-Imd compared to control flies (Figure 5C). As
observed in S2 cells, UbK63-Imd chains were not affected
by Usp2 gene extinction or overexpression (Figure 5C).ed in this study. DD: death domain in Imd, CD: catalytic domain in
osition. B. Drosophila S2 cells were cotransfected with the expression
-ter-V5 as indicated. Cells lysates were coimmunoprecipitated (IP) with
ith either anti-Myc or anti-V5 antibodies as indicated. C. S2 cells were
48 h. Cells lysates were pre-cleared and subjected to GST pull down
USP2-C-ter [475–856] - or with GST alone (GST). Gel was coloured
D. GST-fusion of the wild type (USP2CD) or mutated (USP2CDC540S
-gal for 4 hours at 28°C in transformed E. coli XL1 Blue. Substrate
Figure 5 USP2 hydrolyses Imd-linked UbK48. A. Drosophila S2 cells were cotransfected with Imd-V5 and either wild type USP2 or mutant USP2C540S
(USP2C*) expressing constructs in untreated cells or cells treated with MG132 at 20 μM for 4 hours before cell lysis. Imd-V5 was immunoprecipitated with
anti-V5 antibodies (IP V5) and Imd-ubiquitinated forms were detected by western blot with either anti-UbK63 (WB K63) or anti-UbK48 (WB K48) antibodies as
indicated. Imd full length was detected with anti-V5 antibodies (IP V5 WB V5). Expression of USP2 was assessed by western blot of whole cell lysate with
anti-Myc antibodies (WB Myc). B. Drosophila S2 cells were cotransfected with Imd-V5 in the presence or not of Usp2 silencing dsRNA (dsUsp2). Imd-V5 was
immunoprecipitated with anti-V5 antibodies and Imd-ubiquitinated forms were detected by western blot with anti-UbK48 antibodies (IP V5 WB K48). Imd
full length was detected in the cell lysate with anti-V5 antibodies (WB V5). C. Endogenous Imd was immunoprecipitated with anti-Imd antibodies from
extracts of c564/+ control flies (Ctrl), or flies expressing either the Usp2 silencing transgene (Usp2-IR), or the wild type (USP2) or the catalytically inactive
form (USP2C*) of USP2, under the control of the c564Gal4 driver line (IP Imd). Ubiquitinated forms of Imd were detected with either UbK63 (WB K63) or
UbK48 (WB K48) antibodies as indicated. The amount of endogenous Imd proteins was detected in total fly extracts with Imd antibodies (WB Imd).
A-C. Anti-tubulin antibodies served as loading control (WB Tub).
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deubiquitinating enzyme specifically promoting the hy-
drolysis of UbK48 linked to Imd.
USP2 promotes Imd degradation by the proteasome
Our data indicate that Imd is permanently linked by
UbK48 putatively ensuring its turnover through proteaso-
mal degradation. Indeed, inhibiting the proteasome in
S2 cells with MG132 led to the accumulation of full-
length and cleaved Imd when compared to untreated
control cells (Figure 6A). Remarkably, silencing Usp2
also provoked a clear accumulation of full length and
cleaved Imd compared to control cells reaching similar
amount as in MG132 treated cells (Figure 6A). Likewise,
silencing of Usp2 in the fat body resulted in the accumu-
lation of endogenous Imd (Figure 6B). This is surprising
because we have previously shown that USP2 promotes
the hydrolysis of UbK48 linked to Imd, a process which is
expected to save Imd from proteasomal degradation. On
the opposite, our results clearly indicate that Usp2 silen-
cing induces a blockade in the Imd degradation process
thus suggesting that USP2 is required for Imd degrad-
ation. By contrast, the amount of the Toll pathwaycomponent Cactus was not modified by silencing Usp2
in S2 cells (Figure 6C).
Since a proper immune response would require stable
Imd, we investigated whether bacterial infection modifies
the amount of UbK48-linked and full length Imd. Strik-
ingly, UbK48-Imd accumulation seen in Usp2-silenced
flies was strongly reduced in infected flies compared to
uninfected flies indicating that the linkage of UbK48 on
Imd is actively prevented in response to immune chal-
lenge, thus allowing for Imd stabilisation (Figure 6D).
To investigate whether accumulation of Imd protein
could be sufficient to induce ectopic activation of the
Imd pathway in vivo, we blocked proteasome function in
flies expressing two conditional dominant-negative prote-
asome subunits (UAS-pros261ts; UAS-prosβ21ts) [28]. Flies
kept at the restrictive temperature (30°C) for 72 hours
accumulated UbK48 –linked and full length Imd (Figure 6E)
and concomitantly, they displayed significant activation of
the AttA and Dpt expression (Figure 6F). Altogether, our
results suggest an essential role of USP2 in both the
hydrolysis of UbK48 linked to Imd and the proteasomal
degradation of Imd thus preventing its accumulation and
subsequent constitutive activation of the Imd pathway.
Figure 6 Imd proteasomal degradation requires USP2. A. S2 cells were transfected by Imd-V5 expressing construct and treated or not by
Usp2 silencing dsRNAs (dsUsp2). Cells were incubated or not with MG132 at 20 μM. Cell lysates were immunoblotted with anti-V5 antibodies (WB
V5). B. Protein extracts of c564/+ control or c564/Usp2-IR flies were immunoblotted with anti-Imd antibodies (WB Imd). C. S2 cells lysates treated
or not with dsUsp2 were immunoblotted with anti-Cact antibodies (DSHB) (WB Cact). D. Endogenous Imd was immunoprecipitated from extracts
of c564/+ or c564/Usp2-IR flies infected or not by E. coli. Ubiquitinated forms of Imd were detected with anti-UbK48 antibodies (IP Imd WB K48).
Total extracts were immunoblotted with anti-Imd antibodies (WB Imd). E. Endogenous Imd was immunoprecipitated from extracts of c564/+ or
c564/Pros26[1]; Prosbeta[1]/+ flies (c564 > ProsDN). Ubiquitinated forms of Imd were detected by anti-UbK48 antibodies (IP Imd WB K48). A-E:
Anti-tubulin immunoblots served as loading control (WB Tub). F. Quantitative analysis of Dpt and AttA mRNAs from c564 > ProsDN compared to
c564/+ control flies. Histograms present the fold activation of each mRNA. Error bars indicate standard deviation between technical triplicates.
Significant differences with control (t-test) p < 0.001 (***). G. S2 cells were cotransfected with pAc-USP2-Myc and either pAc-Imd or a control
empty plasmid (Ctrl). USP2 was immunoprecipitated with anti-Myc antibodies and immunoblotted with anti Pros45 antibody (DHSB) (IP Myc
WB Pros45). Cells lysates were immunoblotted with anti-Myc and anti Pros45 antibodies (WB Myc, WB Pros45). H. S2 cells were cotransfected with
pAc-Imd-V5 and either pAc-Usp2 or a control empty plasmid (Ctrl). Imd was immunoprecipitated with anti-V5 antibodies and endogenous Pros45
was detected (IP V5 WB Pros45). Whole cells lysates were revealed with anti-V5 and anti Pros45 antibodies (WB V5 WB Pros45).
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proteasome
To investigate how USP2 might ensure its regulatory
function on Imd homeostasis, we realised a pull-down
assay using S2 cell lysate and GST or GST-USP2 as baits
to identify USP2-interacting proteins. Eluates were then
analysed by a tandem mass spectrometry-based prote-
omic approach. Among other candidates specifically
identified as associated with GST-USP2 (Additional file
3: Table S2), the proteasomal subunit 8 (Pros45) may
trigger USP2 binding to the proteasomal machinery.
Indeed, endogenous Pros45 co-immunoprecipitate with
USP2-Myc (Figure 6G). Interestingly, a much higher
amount of this proteasomal subunit was detected in the
presence of overexpressed Imd (Figure 6G). Reciprocally,
while Pros45 was hardly detectable in the purified prod-
uct from immunoprecipitated Imd-V5, it was clearly
observed when USP2 was overexpressed (Figure 6H).
Thus, the Imd–USP2 complex apparently binds more ef-
ficiently to the proteasome than do Imd or USP2 alone.
Taken together, our data suggest that USP2 and Imd
synergistically bind to the proteasome and that USP2
contributes to Imd degradation at the proteasome level.
Discussion
By using an RNAi screening approach, we demonstrate
here the importance of three ubiquitin proteases, USP2,
USP34 and USP36, in the regulation of the Imd immune
signalling pathway. In addition, USP34 was identified as
the only negative regulator of the Toll pathway in this
screen. While this study and previous work [17] show a
clear negative regulatory function for USP2 and USP36
on the Imd pathway in both un-infected and infected
flies, USP34 can have both negative, (i.e., on AttA, Drs
and IM1) and a positive (i.e., on Dpt and Def ), regulatory
functions on antimicrobial peptide genes in infected
flies. Similar differential effect on various antimicrobial
peptide genes induction has been observed with the
POSH E3 ligase targeting TAK1 [29] while only a subset
of Imd target genes (i.e., Dpt and Dro but not AttA and
CecA1) are affected in a faf (fat facets) mutant, where faf
encodes a deubiquitinating enzyme targeting Imd [30].
Our result suggest a complex requirement of USP34
putatively acting at different levels of these two path-
ways. In unchallenged conditions, USP34 may interfere
with common negative regulatory mechanisms preven-
ting ectopic transcriptional activation of NF-κB target
genes while in challenged conditions, USP34 may target
components that are differentially required in the two
pathways.
Focusing on the function of USP2, we found that it in-
teracts with Imd and specifically promotes the hydrolysis
of UbK48 from the protein, thus displaying different
substrate specificity than USP36 which was previouslydescribed to promote the hydrolysis of UbK63 from Imd
[17]. Whereas the linkage of UbK63 on Imd activates sig-
nal transduction [17,31], we show here that UbK48 serves
as a tag for Imd degradation by the proteasome. Thus,
differential ubiquitination of Imd regulates either its ac-
tivity or its stability and is tightly controlled by the com-
plementary activity of USP36 and USP2 (Figure 7). Even
though they target different ubiquitin chains and have
different effects on Imd, both enzymes contribute to
down-regulation of the Imd pathway.
Actually, it was first rather surprising that while USP2
promotes the cleavage of UbK48 from Imd, its physio-
logical function is not to rescue Imd from degradation
but rather to promote its degradation by the prote-
asome. This was clearly demonstrated by using silencing
experiments: in Usp2-silenced cells, or in flies expressing
the Usp2-IR silencing transgene, UbK48 and full-length
Imd accumulated indicating a blockade of the Imd
degradation process. At the molecular level, the simplest
explanation for this result is that USP2 drives the UbK48-
Imd molecules to the proteasome and/or ensures the re-
moval of UbK48 from Imd at the level of the proteasome,
then allowing for Imd degradation by the proteasome
machinery (Figure 7). Indeed, the release of attached
polyubiquitin chain is necessary to permit the entry of a
specific substrate to the proteasomal cavity [32,33].
Moreover, it has been recently illustrated that deubiqui-
tination by the yeast enzyme Ubp3 –which interacts
with the 26S proteasome subunit- can either save pro-
teins from destruction or facilitate protein destruction
by the 26S proteasome, depending on stress conditions
and Ubp3 amount in the cell [34]. Our evidence that
USP2 interacts with Pros45, the 26S subunit 8 of the
proteasome, and that this interaction is significantly en-
hanced in the presence of Imd supports similar essential
role of USP2 in Imd degradation at the level of the pro-
teasome. Interestingly, artificial overproduction of USP2
by tissue-directed or heat-shocked-induced expression of
the Usp2 expressing transgene in non-infected flies, also
leads to Imd accumulation (data not shown). Therefore,
as shown for Ubp3, depending on its total amount,
USP2 may either save a target protein from degradation
by the proteasome or favour its degradation.
The accumulation of Imd in Usp2-silenced flies most
probably contributes to the observed constitutive induction
of Imd-dependent AMP gene expression. Consistent with
this, blocking the proteasome by expressing dominant-
negative proteasome subunits in transgenic flies similarly
resulted in accumulation of full length Imd concomitantly
with constitutive activation of the Imd pathway. The
molecular mechanisms underlying ectopic activation of the
Imd pathway, when Imd is overexpressed or inefficiently
degraded, are not known. Notably, it should be assess in
the future whether it is associated or not with increased
Figure 7 (Summary illustration): Three USPs regulate Imd activation or stability and downstream signalling. Three ubiquitin specific
proteases regulate the Imd pathway, USP34 is putatively acting at the level of NF-κB like factors associated complexes (Rel in the case of Imd pathway)
while USP2 and USP36 differentially targets the scaffolding molecule Imd by hydrolysing UbK48 (this study) and UbK63 [17] chains, respectively. Imd is
subjected to a permanent turn-over via the linkage of UbK48 ubiquitin chains and subsequent proteasomal degradation. This prevents Imd accumulation
and constitutive signal activation in unchallenged conditions. The deubiquitinating enzyme USP2 is required for both UbK48 hydrolysis and
Imd degradation at the level of the proteasome. In response to an immune challenge, the activity of the E3 ligase would be prevented
resulting in the observed Imd stabilisation and accumulation. It has been previously described that Imd activation in response to immune
challenge results in its cleavage by Dredd and linkage of UbK63 by Iap2 [31]. USP36 deubiquitinates Imd linked UbK63 thus preventing
inappropriate or excessive signal transduction and putatively promoting ubiquitin chain editing through the replacement of activating
UbK63 by UbK48 degradative chains [17].
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mune challenge that would activate the E3 ligase Iap2,
which is responsible for the linkage of K63 chains on Imd
[31], Imd accumulation and self-aggregation may favour
the self-assembly of activating complexes independently of
the linkage of ubiquitin moieties. Interestingly, similar acti-
vation of Dpt expression was previously observed following
proteasomal inhibition and was associated with Rel stabil-
isation [35]. Thus, proteasome activity, by acting on several
components of the pathway (at least Imd and Rel), likely
has an important function in damping down immune
signalling in the absence of infection.
Remarkably, the accumulation of UbK48 -Imd seen in
Usp2-silenced flies mostly disappeared following an im-
mune challenge. Subsequently, Imd is significantly stabi-
lised in challenged flies compared to unchallenged flies.
Since Usp2 was silenced in these flies, this disappearanceof UbK48 -Imd cannot be a consequence of USP2 deubi-
quitinating activity. Rather, we suggest that infection in-
hibits the linkage of UbK48 to Imd by an unidentified E3
ubiquitin ligase and/or activate another DUB that would
cleave K48 ubiquitin chains linked to Imd.
The human homologs of USP2 and USP34 also play
regulatory roles in NF-κB-dependent immune signalling.
One study reported that USP34 is a regulator of T-cell
receptor (TCR)-dependent lymphocyte activation where
it acts as a down-regulator of NF-κB signalling [36].
Although its molecular target remains to be identified,
USP34 functions downstream of the IKK complex in
human cells, putatively on proteins that would be com-
monly required in these different NF-κB signalling path-
ways. The fact that USP34 is required in the two NF-κB
immune signalling pathways Toll and Imd also argues in
favour of USP34 targeting common regulatory mechanisms
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is reinforced by the observation that in response to infec-
tion, USP34 differentially regulates AMP genes expression
which may typically reflect differential activity at the level
of NF-κB-containing complexes. Of note, however, co-
silencing of the scaffolding proteins Imd or dMyd88 fully
disrupted the PGRP-LC- or the Toll-dependent activation
of immune signals observed in Usp34-silenced condition,
respectively. This suggests that these upstream molecules
are required to ensure a minimal activation of NF-κB-like
factors that are then tightly regulated by USP34-dependent
mechanisms that stay to be discovered in both Drosophila
and mammalian models.
A set of different studies point to a regulatory function of
the mammalian USP2a isoform on TNF-R1 dependent acti-
vation of the NF-κB pathway. First, silencing Usp2a con-
tributes to TNFα-dependent hepatocyte survival in mice,
presumably due to enhanced transcriptional activity of
NF-κB [37]. Second, USP2a hydrolyses UbK63 from RIP1
thus preventing NF-κB activation while promoting caspase-
mediated cell death in response to TNFα stimulation in
human cells [38]. Two other studies, by contrast, provide
controversial results by describing a positive role for USP2a
in TNF-R1 dependent NF-κB signalling [39] or in the
regulation of TCR-induced NF-κB activation [40]. These
discrepancies may be due to dose-dependent effects of
USP2 on multiple targets.
Conclusion
In addition to the NF-κB pathway, a huge and increasing
number of proteins and pathways seems to be controlled
by USP2, which is also deregulated in many cancers
[41-46]. Our demonstration of USP2 involvement in the
proteasomal degradation of Imd suggests a more ex-
tended function at the proteasome level than previously
anticipated. It may highlight new mechanisms of action
of USP2 on its targets and provide some molecular
explanations for its tumorigenic function in humans in
the future.
Methods
Cell culture and RNA silencing
Drosophila S2 cells were maintained in Schneider’s Dros-
ophila medium supplemented with 10% heat-inactivated
serum (FCS, Invitrogen). Gene inactivation was achieved
by incubating 0.4 μg double strand RNA (dsRNA) for
48 h at 26°C with 1.2×105 S2 cells cultured in 96-well
microplates (adapted from [47]. DNA templates for
dsRNA synthesis were generated by PCR (MEGAscript
RNAi kit, Ambion) using the primers designed from
Heidelberg Fly Array RNAi libraries (www.genomernai.
org/). To monitor Imd and Toll pathways activation, we
used the reporter constructs pAttA-luc [48] and pDrs-luc
[21], respectively. We further constructed a normaliserpAct-luc (Promega). DNA transfection was performed
48 hours prior to luciferase detection (simultaneously with
dsRNAs). To activate the Imd pathway, heat-killed E. coli
(5×107) were added 4 hours prior to dual detection of the
two luciferases.
Fly strains and infections
Flies were raised on standard culture medium at 25°C
except if indicated. The insertion P[EPgy2]ash2EY03971
was obtained from BDSC. Transgenic lines were con-
structed in the P[UAST] vector [23]. The P[UAS-Usp2]
transgene contains the CG14619-RA cDNA subcloned
from SD02480 (DGRC). Heat-shock driven expression of
Usp2 or Usp34 was achieved as described in [17]. For
in vivo gene silencing, inverted repeats designed from the
Heidelberg RNAi librarie (HFA, www.genomernai.org/) –
that are similar as those used for S2 cell silencing- of
Usp2 and Usp34 were cloned in the PWIZ vector
[49]. Other silencing transgenes, P[UAS-Imd-IR] (#9253);
P[UAS-Usp2-IR](#37930) and P[UAS-Usp34-IR] (#27517)
were obtained from VDRC [25]. Importantly VDRC lines
display different silencing sequences than our home-made
constructs. For infection, fifty 3–5 days old males were
pricked in the thorax with a thin needle that had been
previously dipped in a concentrated overnight culture
(OD600 #400) of E. coli or M. luteus (to measure activa-
tion of the Imd and Toll pathways respectively), or of
K. pneumonia or E. faecalis, to measure flies survival.
Real-time quantitative PCR (RT-qPCR) analysis
Total RNAs were extracted from adult flies using Abso-
lutely RNA Miniprep kit from Stratagene. For real-time
PCR analysis, cDNAs were synthesized with AffinityScript
QPCR cDNA Synthesis Kit (Stratagene). An amount of
cDNA equivalent to 0.01 μg of total RNA was subjected to
40 cycles of PCR amplification consisting of a 10s incuba-
tion at 95°C and 30s at 60°C. Output was monitored using
SYBR Green core reagents and the Mx3000P instrument
(Stratagene). All the results were normalized to the rpl32
RNA level. The primer sequences were designed using
PrimerQuest (http://eu.idtdna.com/Scitools/Applications/
Primerquest/).
In vitro deubiquitinating assays
Mutation in the Usp2 coding sequence (resulting in the
mutated protein USP2C540S) was introduced using
QuickChange XL Site-directed Mutagenesis Kit (Strata-
gene). Wild type or mutated catalytic domains of USP2
[AA 475 to 856] were coexpressed with Ub-β-gal fusion
protein for 4 hours at 28°C in transformed E. coli XL1 Blue.
Bacteria were lysed in 100 μL Laemmli solution. Samples
were subjected to SDS-PAGE (6% gel) and western blotting
with a rabbit anti β-Gal antibody (ROCKLAND).
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Co-immunoprecipitation were performed following stan-
dard procedures in S2 cotransfected cells with 10 μg of
Myc tagged full length USP2 construct in pAc/HisB vector
(Invitrogen) (USP2-Myc) and 10 μg of V5-tagged Imd full
length or truncated constructs. Pull Down assays were
performed in S2 cells transfected with full length Imd-V5
construct and lysed after 48 h. The lysate was employed in
a GST-USP2 N-ter domain [AA 1 to 531] or C-ter domain
[AA 475 to 856] pull down assays. Pull downs were
blotted with antibody against V5 to detect bound Imd-V5.
Proteomic analysis (supporting data deposited in a
database)
Protein digestion and nano-liquid chromatography (LC)–
MS/MS analyses were performed as described in [50]. Only
proteins identified specifically in the USP2 sample and not
in the control one, with a minimum of 6 peptides and spe-
cific spectral counts above 6, were retained (indicated in
green in Additional file 3: Table S2). The mass spectrometry
proteomics data have been deposited to the ProteomeX-
change Consortium (http://www.proteomexchange.org) via
the PRIDE partner repository [51] with the data set identi-
fier PXD000881 and doi:10.6019/ PXD000881.
Additional files
Additional file 1: Table S1. Ubiquitin proteases screened on Imd and
Toll pathways. List of Usps and corresponding CG numbers screened on
Imd and Toll pathway in S2 cells with indication of human closest
homolog gene(s). cDNA templates and primers used for dsRNA synthesis
are indicated. All primers were designed from (http://www.genomernai.
org/). Of note, the USP encoding gene CG8232 was not included in this
study [7,19]. The asterix (*) indicates the Usp genes not screened in [7].
The double asterix (**) indicates an alternative nomenclature used in [7].
Additional file 2: Figure S1. Analysis of Usp36, Usp34 and Usp2 gene
extinction by RT-qPCR in S2 cells treated for 48 h with the indicated
dsRNAs dsGeneName). Figure S2. Activation of Drs promoter was moni-
tored through the pDrs-luc reporter (normalised to pAct-luc)
in transfected cells expressing pAc-Spz and treated for 48 h with the indicated
dsRNAs. NI: no inducer. Figure S3. Analysis of Usp2 and Usp34 expression by
RT-qPCR in HspGal4/+;UAS-Usp2/+ (Hsp>Usp2) or HspGal4/+; P{EPgy2}
ash2EY03971 (Hsp>Usp34) compared to Hsp/+ flies at indicated time points
after heat shock. Figure S4. Analysis of Usp2 (A), Usp34 (B) or Dpt (C,D)
expression by RT-qPCR in total flies (A,C,D) or in dissected guts (B). Indicated
silencing transgenes were induced by heat shock (HS-Gal4) (A) or in the gut
(NP1-Gal4) (B) or in the fat body (c564-Gal4) (C,D). Figure S5. Dpt, AttA or DefC
expression in c564-Gal4/Usp2-IR (#5 M) (A) or c564-Gal4/Usp34-IR (#1 M) (B,C)
compared to c564-Gal4/+ flies. A,C: Flies were infected by E. coli by a septic
injury (100% of activation fixed at 3 h post-infection). Figure S6. Analysis of
Usp2 (A) or Usp34 (B) expression in flies by RT-qPCR at indicated time points
following infection with E. coli or M. luteus. NI: not infected flies.
Slight differences in gene expression were considered not biologically
significant (below 1.6 fold). Figure S7. USP2 preferentially interacts
with Imd-Nter. A. Representation of Imd full length (Imd-FL) and
truncated constructs used in GST pull down assays. CD: catalytic domain in
USP2, C540 catalytic cysteine, DD: death domain in Imd. B. S2 cells were
transfected with pAc-USP2-Myc and lysed after 48 h. Cells lysates were
pre-cleared and subjected to GST pull down using the indicated GST fusion
proteins: Imd FL, Imd-Nter or the Imd-Cter. USP2-Myc was detected by
western blot with anti-Myc antibodies.Additional file 3: Table S2. List of USP2 interacting proteins identified
by a Mass spectrometric analysis. Proteins identified specifically in the
USP2 sample and not in the GST control one with a minimum of 6
peptides and specific spectral counts above 6 are indicated. The full mass
spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium (http://www.proteomexchange.org) via the PRIDE partner
repository [51] with the data set identifier PXD000881 and doi:10.6019/
PXD000881.
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